4 Followers on Owler
Acumen Pharmaceuticals
discovers and develops therapeutics and diagnostics for neurodegenerative disorders...
Acumen Pharmaceuticals
discovers and develops therapeutics and diagnostics for neurodegenerative disorders...
President & CEO
Daniel J O'Connell
1996
PublicIndependent CompanyNASDAQABOS
News
May 09, 2023
Citybizlist
Acumen Pharmaceuticals: Acumen Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Highlights
May 07, 2023
Americanbankingnews
Acumen Pharmaceuticals: Acumen Pharmaceuticals (ABOS) to Release Quarterly Earnings on Tuesday
May 04, 2023
GlobeNewswire
Press Release: Acumen Pharmaceuticals : Acumen Pharmaceuticals to Participate in 2023 Bank of America Healthcare Conference
Mar 28, 2023
Owler
Acumen Pharmaceuticals, Inc.: Acumen Pharmaceuticals's employee count changed from 17 in Mar 2022 to 40 in Mar 2023
Mar 28, 2023
MarketScreener
Acumen Pharmaceuticals: Acumen Pharmaceuticals Presents in vitro Human Neuron Model for Evaluating Binding of Amyloid Beta Oligomers in Alzheimer's Disease
Mar 27, 2023
BioSpace
Acumen Pharmaceuticals: Acumen Pharmaceuticals Reports Financial Results for Full Year Ended December 31, 2022 and Business Highlights
Mar 22, 2023
MarketScreener
Acumen Pharmaceuticals: Acumen Pharmaceuticals to Participate in Stifel 2023 Virtual CNS Days
Nov 15, 2022
Seeking Alpha
Acumen Pharmaceuticals: Acumen Pharmaceuticals, Inc. (ABOS) CEO Daniel O'Connell on Q3 2022 Results - Earnings Call Transcript
Nov 01, 2022
MarketScreener
Acumen Pharmaceuticals: Acumen Publishes Phase 1 Trial Design and Clinical Development Plan for ACU193, an Anti-Amyloid Beta Oligomer Antibody for Alzheimer's Disease
Oct 25, 2022
BioPharma-Reporter
Acumen Pharmaceuticals: New Alzheimer's treatment buoyed by US Fast Track Designation
Looking for similar companies to Acumen Pharmaceuticals?
Acumen Pharmaceuticals News
Acumen Pharmaceuticals Press Releases
Acumen Pharmaceuticals Headquarters
Acumen Pharmaceuticals Summary
ABOUT
Overview
Acumen Pharmaceuticals discovers and develops therapeutics and diagnostics for neurodegenerative disorders. Acumen Pharmaceuticals was founded in 1996. Acumen Pharmaceuticals' headquarters is located in Charlottesville, Virginia, USA 22902. Acumen Ph...CEO
Acumen Pharmaceuticals's President & CEO, Daniel J O'Connell, currently has an approval rating of 67%. Acumen Pharmaceuticals's primary competitors are KalGene Pharmaceuticals, Prothena & Cognition.Website
acumenpharm.comAcquisitions
There have been no acquisitions found related to Acumen PharmaceuticalsFunding
Funding data cannot be found related to Acumen PharmaceuticalsInvestments
Recent investment data cannot be found related to Acumen PharmaceuticalsFrequently Asked Questions about Acumen Pharmaceuticals
When was Acumen Pharmaceuticals founded?
Acumen Pharmaceuticals was founded in 1996Who is Acumen Pharmaceuticals's CEO?
Acumen Pharmaceuticals's CEO is Daniel J O'ConnellHow much revenue does Acumen Pharmaceuticals generate?
Acumen Pharmaceuticals generates $1.4M in revenueHow much funding does Acumen Pharmaceuticals have?
Acumen Pharmaceuticals has historically raised $0 in funding
Where is Acumen Pharmaceuticals's headquarters?
Acumen Pharmaceuticals's headquarters is in Charlottesville Virginia, USAHow many employees does Acumen Pharmaceuticals have?
Acumen Pharmaceuticals has 20 employeesWhat sector does Acumen Pharmaceuticals operate in?
Acumen Pharmaceuticals is in PharmaceuticalsWho are Acumen Pharmaceuticals's competitors?
Acumen Pharmaceuticals's top competitors are KalGene Pharmaceuticals, Prothena, Cognition